A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.
The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
2. Psychotogenesis Overview
3. Diagnosis: OCD/Schizo-Obsessive
4. Diagnosis: Panic/Panic Psychosis
5. Diagnosis: Social Anxiety/Delusional Disorder
6. Diagnosis: Melancholia/Delusional Depression
7. Diagnosis: Atypical Depression/Mania
8. Diagnosis: Substance Abuse Psychosis
André Barciela Veras, MD, PhD, Department of Psychiatry, University of the State of Mato Grosso do Sul, Campo Grande – MS, Brazil and Jeffrey P. Kahn, MD, Weill-Cornell Medical College, New York, New York